Quick Take
Elanco Animal Health (ELAN) announced it has acquired Prevtec Microbia for up to $76.3 million in up front and contingent consideration.
Prevtec provides the Coliprotec vaccine products line for pigs against post-weaning diarrhea [PWD] and associated clinical signs caused by Escherichia coli.
ELAN acquired Prevtec to bring in-house vaccine technologies it was already distributing, and plans to expand its use to new geographies.
Target Company
Montreal, Canada-based Prevtec Microbia was founded in 2003 and has developed the Coliprotec vaccine line for pigs, whose exclusive distributor in Europe and Canada is Elanco.